A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

Similar documents
A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Breast pathology. 2nd Department of Pathology Semmelweis University

Breast Pathology. Breast Development

ACRIN 6666 Therapeutic Surgery Form

Papillary Lesions of the breast

BREAST PATHOLOGY. Fibrocystic Changes

Diseases of the breast (1 of 2)

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Protocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm

Surgical Pathology Issues of Practical Importance

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Immunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy

BREAST PATHOLOGY MCQS

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Overview of AJCC 8 th Staging in Pathologic Aspects

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

NAME/ AGE/57 SEX/Female AREA/Australia Visit 1: 5/8/2011. Right Breast Cancer Infiltrating Ductal Carcinoma, no specific type, Grade 1 to 2.

CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

A215- Urinary bladder cancer tissues

A103(9)- Normal tissues, more than single spots

Basement membrane in lobule.

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Low-Grade Periductal Stromal of Breast: a case report

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Salivary Glands 3/7/2017

Image guided core biopsies:

PATHOLOGY OF THE BREAST

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Adenomyoepithelial adenosis associated with breast cancer: a case report and review of the literature

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

PRINCIPLES OF BREAST SURGERY & COMPLICATIONS

Pathology Report Patient Companion Guide

Recent advances in breast cancers

Flat Epithelial Atypia

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Evaluation of Breast Specimens Removed by Needle Localization Technique

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Papillary Lesions of the Breast: WHO Update

Collaborative approach to national implementation of Standardization Pathology Reporting. June 2014 Avril Kwiatkowski

RSNA, /radiol Appendix E1. Methods

HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS

Sentinel nodes. Location: Location: S1.04 Principal clinician. G1.01 Record other relevant information. S2.01 Number of specimens submitted

How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer

TOTALS 30. Preliminary analysis of NNDEQA 004 (May 2013 TSL workshops) 1) 70 year old female with focal irregularity in the right breast.

A218 : Esophagus cancer tissues. (formalin fixed)

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.

Benign Mimics of Malignancy in Breast Pathology

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

INDEX. in this web service Cambridge University Press

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

Cytyc Corporation - Case Presentation Archive - March 2002

DOCTORAL THESIS SUMMARY

American Journal of Cancer Case Reports. Invasive Papillary Carcinoma of Male Breast: A Rare Case Report

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

NEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Definition of Synoptic Reporting

Overview of Pathology Evaluation of Breast Lesions and Quality Assurance

Cystic Hypersecretory Carcinoma of the Breast:

Invasive Papillary Breast Carcinoma

Benign, Reactive and Inflammatory Lesions of the Breast

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

COPE Library Sample

Diagnostic Problems in Breast Pathology How to avoid the pitfalls

University Journal of Pre and Para Clinical Sciences

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help:

Benign Breast Disease and Breast Cancer Risk

Criteria of Malignancy. Evaluation Score

Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast

A rare presentation of malignant phyllodes tumor with bloody nipple discharge report of a case

Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature

1. Guidelines for Reporting Carcinoma of the Breast

BMaP-3 Cancer Database. Aggregate Data File

Invasive Cribriform Carcinoma Arising in Malignant Phyllodes Tumor of Breast: A Case Report

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

FIBROEPITHELIAL LESIONS

Papillary Lesions of the Breast

Case Report Basaloid ductal carcinoma in situ arising in salivary gland metaplasia of the breast: a case report

Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Protocol for the Examination of Resection Specimens From Patients With Invasive Carcinoma of the Breast

Table of contents. Page 2 of 40

High risk lesions of the breast : Review of the current diagnostic and management strategies

1 NORMAL HISTOLOGY AND METAPLASIAS

Segmental Breast Calcifications

COMMON BENIGN DISORDERS AND DISEASES OF THE BREAST

Transcription:

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding normal tissues No. of spots: 1 spot from each cancer case (12 spots) 12 non-neoplastic spots (12 spots) Total spots: 24 Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm Documents: Product specification: layout, summary of tissue spots H&E stained images Detailed pathological information Layout: P-07-04-10T

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues Summary of tissue spots (formalin fixed) For research use only P-07-04-11T

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only QC sheet_lot# 132121112191 Hematoxylin and Eosin staining A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5 E1 E2 F1 F2 P-07-04-12T

1 A 1 f 62 Breast, right, partial mastectomy: 1. Size: 1.8x1.2cm 2. Black's nuclear grade: II (moderately differentiated) 3. Modified Bloom-Richardson's histological grade: III (tubule formation: III, nuclear pleomorphism: II, mitosis: III) 4. Intraductal component: less than 5% 5. Resection margins: Negtive 6. Vascular invasion: Absent 7. Perineural invasion: Absent 8. Microcalcification: Absent 9. Immunohistochemistry: ER(-), PR(-), C erb B2(+:3+/3+) Lymph node, sentinel(0/1): Free of tumor. 2 B 1 f 62 non-neoplastic non-neoplastic from A1 3 A 2 f 79 Breast, right, modified radical mastectomy: 1. Size: 2x1.8x1.5cm 2. Site: RIL quadrant, 4cm away from the nipple 3. Black's nuclear grade: II (moderately differentiated) 4. Modified Bloom-Richardson's histological grade: II (tubule formation: III, nuclear pleomorphism: III, mitosis: I) 5. Intraductal component: 5% 6. Resection margins: Negative 7. Vascular invasion: Absent 8. Immunohistochemistry: ER(+), PR(+), C erb B2(-) Nipple and areola: Free from tumor extension. Overlying skin: Extension of the tumor. Underlying fascia: Free from tumor extension. Lymph node, axillary(0/17): Free from tumor extension. 4 B 2 f 79 non-neoplastic non-neoplastic from A2

5 A 3 f 54 Breast, left, modified radical mastectomy: 1. Size: 1.3x1.0cm 2. Black's nuclear grade: II (moderately differentiated) 3. Modified Bloom-Richardson's histological grade: I (tubule formation: I, nuclear pleomorphism: II, mitosis: I) 4. Intraductal component: < 5% 5. Resection margins: Negative 6. Vascular invasion: Absent 7. Perineural invasion: Absent 8. Microcalcification: Present in invasive cancer, in ductal in situ, in associated with benign epithelium, in stroma immunohistochemistry: ER(+), PR(+), C erb B2(-:0/3+) 10. Ductal in situ in the background 1) Nuclear grade: Low 2) Histological grade: Low 3) Necrosis: Absent 4) Architectural types: Micropapillary 5) Extent of DCIS: Approximately 4x3.5cm 6) Microinvasion: Absent 11. Associated benign change: Adenosis and papillomatosis. Underlying fascia: Free of tumor. Lymph node, sentinel(0/3): Free of tumor. Breast, right, mastectomy: Main mass: Infiltrating ductal, nuclear grade II,Histologic grade II with minimal intraductal component (< 5%). Surrounding parenchyma: 1. Ductal in situ, low grade. 2. Papillomatosis. 3. Adenosis. Underlying fascia; free of tumor Result of immunohistochemistry.:er, PR; positive / C erb B2; negative 6 B 3 f 54 non-neoplastic non-neoplastic from A3

7 A 4 f 54 Breast, left, partial mastectomy: 1. Size: 2.2x1.5x1.0cm 2. Black's nuclear grade: II (moderately differentiated) 3. Modified Bloom-Richardson's histological grade: III (tubule formation: III, nuclear pleomorphism: II, mitosis: III) 4. Intraductal component: 15% 5. Resection margins: negative 6. Vascular invasion: Present 7. Perineural invasion: Absent 8. Microcalcification: Absent 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:1/3 +) Lymph node, sentinel(0/1): Free of tumor. 8 B 4 f 54 non-neoplastic non-neoplastic from A4

9 A 5 f 61 Breast, left, modified radical mastectomy: 1. Size: 4.3x2.2cm 2. Site: LUO quadrant, 2 o'clock area, 5cm away from the nipple 3. Black's nuclear grade: I (poorly differentiated) 4. Modified Bloom-Richardson's histological grade: III (tubule formation: III, nuclear pleomorphism: III, mitosis: III) 5. EIC: present 6. Vascular invasion: Absent 7. Perineural invasion: Absent 8 Microcalcification: Absent 9.Immunohistochemistry: ER(-), PR(+), C erb B2(-:1+/3+) 10. Associated benign changes: Ductal in situ in the background 1) Nuclear grade: High 2) Histological grade: High 3) Necrosis: Present (punctate) 4) Architectural types: Solid, Micropapillary 5) Extent of DCIS: 7.3x6cm 6) Calcification: Absent 7) Microinvasion: Present, multifocal Nipple and areola: Free of tumor. Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, axillary(3/12): Tumor metastasis in 3 out of 12 lymph nodes without pericapsular tumor spread (the largest tumor deposit: 1.1x0.8cm) 10 B 5 f 61 non-neoplastic non-neoplastic from A5

11 C 1 f 69 12 D 1 f 69 non-neoplastic non-neoplastic from C1 13 C 2 f 45 Phyllodes tumor 14 D 2 f 45 non-neoplastic non-neoplastic from C2 15 C 3 f 58 16 D 3 f 58 non-neoplastic non-neoplastic from C3 Breast, right, partial mastectomy: 1. Size: 2.2x1.3cm 2. Black's nuclear grade: I (poorly differentiated) 3. Modified Bloom-Richardson's histological grade:iii (tubule formation: III, nuclear pleomorphism: III, mitosis: III) 4. Intraductal component: 10% 5. Resection margins: Negative 6. Vascular invasion: Absent 7. Perineural invasion: Absent 8. Microcalcification: Present in invasive cancer, in ductal in situ 9. ER(+), PR(+), C erb B2(weak+:2+/3+) Underlying fascia: Free of tumor. Lymph node, sentinel(0/2): Free of tumor. Breast, site unstated, excision: 1. Phyllodes tumor, borderline(low grade malignant), with florid ductal epithelial hyperplasia. 2. The sections show moderately cellular stroma with characteristic leaf-like pattern. 3. Focally noted is increased mitoticactivity (2 to 3 per 10 hpf) and moderate cellular atypia. Breast, left, excision: Infiltrating ductal with predominant cribriform pattern 1. size: 2.5x2.5x1.5cm. 2. Black's nuclear grade II (moderately differentiated). 3. modified Bloom-Richardson's histological grade II (tubule formation:i, nuclear pleomorphism:ii, mitosis:iii). 4. no lymphovascular permeation. 5. non-neoplastic breast: Fibrocystic change with apocrine metaplasia. 6.Result of immunohistochemical stainingnote: ER(+), PR(+), C erb B2(-).

17 C 4 f 66 18 D 4 f 66 non-neoplastic non-neoplastic from C4 19 C 5 f 54 infiltrating ductal 20 D 5 f 54 non-neoplastic non-neoplastic from C5 Breast, right, partial mastectomy: 1.Infiltrating ductal, with 1) Bloom and Richardson's histologic grade: II (tubule formation:iii, nuclear grade:ii, mitotic index:ii). 2) Black's nuclear grade: II. 3) no definitive lymphatic invasion. 4) intraductal componenht: 10%. 2.Mammary duct ectasia with calcification. 3.Fibroadenomatoid hyperplasia with calcification. 4.Result of immunohistochemical staining: ER(-), PR(-), C erb B2(+). 5.Result of flow cytometry: Diploid DNA pattern. Breast, left, modified radical mastectomy: Infiltrating ductal 1) modified Bloom 2) Richardson's histological grade: III (tubule formation: II, nuclear pleomorphism: III, mitotic activity: III) 3) Black's nuclear grade: I 4) occasional vascular invasion 5) no intraductal component 6) size of the tumor: 6x4.5x2.3cm 7) surrounding parenchyme: papillomatosis 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5. Lymph nodes, axillary(2/17): Metastasis in 2 out of 17 nodes. 6. Result of immunohistochemical stain: ER(-), PR(+), C erb B2(2+/3)

21 E 1 f 70 infiltrating ductal Breast, left, modified radical mastectomy: infiltrating ductal with 1) modified Bloom and Richardson's histologic grade: II (tubule formation: II, nuclear pleomorphism: II, mitotic index: III) 2) Black's nuclear grade: II 3) intraductal component: 1% 4) no lymphovascular invasion 5) size: 2.5x2x1.4cm and 0.7x0.7x0.5cm 6) nipple and areola: free of tumor 7) overlying skin and underlying fascia: free of tumor 8) lymph nodes, axilla(0/8): free of tumor metastasis in all 8 nodes 9) result of immunohistochemical staining: ER(+), PR(+), C erb B2(+,-:2+). 22 F 1 f 70 non-neoplastic non-neoplastic from E1 23 E 2 f 38 infiltrating ductal 24 F 2 f 38 non-neoplastic non-neoplastic from F1 Breast, left, modified radical mastectomy: 1.Infiltrating ductal 1) size: 6x4.5cm 2) histologic grade I (tubular formation II, pleomorphism II, mitosis I) 3) nuclear grade II 4) intravasclar permeation: uncertain 5) intraductal component, about 30% 2.Nipple and areola: Free of tumor. 3.Overlying skin and underlying fascia: Free of tumor. 4.Regional lymph nodes: Free of tumor in all nodes (0/18).